ATE130437T1 - Immuntest und reagenzien zum nachweis von durch schwangerschaft hervorgerufenem bluthochdruck und eklampsie. - Google Patents

Immuntest und reagenzien zum nachweis von durch schwangerschaft hervorgerufenem bluthochdruck und eklampsie.

Info

Publication number
ATE130437T1
ATE130437T1 AT89117065T AT89117065T ATE130437T1 AT E130437 T1 ATE130437 T1 AT E130437T1 AT 89117065 T AT89117065 T AT 89117065T AT 89117065 T AT89117065 T AT 89117065T AT E130437 T1 ATE130437 T1 AT E130437T1
Authority
AT
Austria
Prior art keywords
eclampsia
reagents
during pregnancy
immune test
hypertension during
Prior art date
Application number
AT89117065T
Other languages
English (en)
Inventor
Andrew E Senyei
Nelson N H Teng
Original Assignee
Adeza Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adeza Biomedical Corp filed Critical Adeza Biomedical Corp
Application granted granted Critical
Publication of ATE130437T1 publication Critical patent/ATE130437T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT89117065T 1988-09-15 1989-09-14 Immuntest und reagenzien zum nachweis von durch schwangerschaft hervorgerufenem bluthochdruck und eklampsie. ATE130437T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24497088A 1988-09-15 1988-09-15
US07/302,854 US5079171A (en) 1988-09-15 1989-01-27 Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin

Publications (1)

Publication Number Publication Date
ATE130437T1 true ATE130437T1 (de) 1995-12-15

Family

ID=26936926

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89117065T ATE130437T1 (de) 1988-09-15 1989-09-14 Immuntest und reagenzien zum nachweis von durch schwangerschaft hervorgerufenem bluthochdruck und eklampsie.

Country Status (10)

Country Link
US (1) US5079171A (de)
EP (1) EP0359274B1 (de)
JP (1) JP2597013B2 (de)
AT (1) ATE130437T1 (de)
AU (1) AU623678B2 (de)
CA (1) CA1338899C (de)
DE (1) DE68924818T2 (de)
ES (1) ES2079366T3 (de)
GR (1) GR3018101T3 (de)
IL (1) IL91639A0 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI892197A (fi) * 1989-05-08 1990-11-09 Locus Oy Foerfarande foer detektering av tumoerer.
AU7674591A (en) * 1990-04-12 1991-11-11 Adeza Biomedical Corporation Pregnancy induced hypertension and eclampsia immunoassay and reagents
WO1992017604A1 (en) * 1991-03-26 1992-10-15 Otsuka Pharmaceutical Factory, Inc. Anti-eda monoclonal antibody
EP0584343B1 (de) * 1992-03-10 1999-01-20 La Jolla Cancer Research Foundation Rekombinierte alkalische phosphatase aus kälberdarm
US5543138A (en) * 1994-03-10 1996-08-06 Genetics Institute, Inc. Methods of diagnosing and treating preeclampsia
EP0722087B1 (de) * 1994-07-29 2005-06-29 Mitsubishi Kagaku Iatron, Inc. Mess-system unter verwendung von vollblut
US5849474A (en) * 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals
GB9614615D0 (en) * 1996-07-11 1996-09-04 Isis Innovation Diagnosis of pre-eclampsia
US6620590B2 (en) 1996-07-11 2003-09-16 Isis Innovation Limited Diagnosis of pre-eclampsia
DE19631192C2 (de) * 1996-08-03 1998-09-10 Hellmut Dr Augustin Verfahren zur Früherkennung gestosegefährdeter schwangerer Frauen
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6284194B1 (en) 1998-03-11 2001-09-04 Albert E. Chu Analytical assay device and methods using surfactant treated membranes to increase assay sensitivity
USD434153S (en) * 1998-04-20 2000-11-21 Adeza Biomedical Corporation Point of care analyte detector system
USD432244S (en) * 1998-04-20 2000-10-17 Adeza Biomedical Corporation Device for encasing an assay test strip
GB9927125D0 (en) * 1999-11-16 2000-01-12 Univ Reading The Placental human neurokinin B precursor
US6642055B1 (en) 2000-03-31 2003-11-04 Arbogast Pharmaceuticals, Inc. Method for the prediction of preeclampsia and other diseases
WO2004071273A2 (en) * 2003-02-04 2004-08-26 The Administrators Of The Tulane Educational Fund Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
WO2004071427A2 (en) 2003-02-06 2004-08-26 Adeza Biomedical Corporation Screening and treatment methods for prevention of preterm delivery
US20080010024A1 (en) * 2003-09-23 2008-01-10 Prediction Sciences Llp Cellular fibronectin as a diagnostic marker in cardiovascular disease and methods of use thereof
US7392140B2 (en) * 2003-09-23 2008-06-24 Prediction Sciences, Llc Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US7634360B2 (en) * 2003-09-23 2009-12-15 Prediction Sciences, LL Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
US20060024757A1 (en) * 2004-07-30 2006-02-02 Robert Hussa Detection of oncofetal fibronectin for selection of concepti
KR20070092737A (ko) * 2004-12-15 2007-09-13 베스 이스라엘 데코니스 메디칼 센터 임신 합병증의 진단 및 치료에 유용한 핵산 및 폴리펩티드
US20100190192A1 (en) * 2005-09-15 2010-07-29 Victor Voroteliak Method of diagnosing pre-eclampsia
AU2008214837B2 (en) 2007-02-12 2013-01-10 A1M Pharma Ab Diagnosis and treatment of preeclampsia
WO2009097584A1 (en) * 2008-01-30 2009-08-06 Proteogenix, Inc. Maternal serum biomarkers for detection of pre-eclampsia
PT2550535E (pt) 2010-03-24 2015-09-07 Preelumina Diagnostics Ab Hbf e a1m como marcadores de fase inicial para pré- eclâmpsia
BR112013007311A2 (pt) 2010-10-01 2016-07-05 Hologic Inc tira de teste de imunoensaio para uso em um sistema de diagnóstico
WO2013000992A1 (en) 2011-06-28 2013-01-03 Vitateq Biotechnology Gmbh Method for diagnosing preeclampsia
DK2836843T3 (da) * 2012-04-13 2020-08-24 Prediction Biosciences Sas Hurtigtest til cellulært fibronektin
RU2740852C1 (ru) * 2020-07-27 2021-01-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный университет" Министерства здравоохранения Российской Федерации Способ прогнозирования преэклампсии у беременных с гестационным сахарным диабетом

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0616048B2 (ja) * 1983-10-26 1994-03-02 帝国臓器製薬株式会社 フィブロネクチンの免疫学的測定
US4980279A (en) * 1986-04-15 1990-12-25 Scripps Clinic And Research Foundation Cellular fibronectin: polypeptides, anti-polypeptide antibodies and assay methods

Also Published As

Publication number Publication date
US5079171A (en) 1992-01-07
ES2079366T3 (es) 1996-01-16
AU623678B2 (en) 1992-05-21
DE68924818T2 (de) 1996-05-02
JP2597013B2 (ja) 1997-04-02
CA1338899C (en) 1997-02-11
EP0359274A2 (de) 1990-03-21
GR3018101T3 (en) 1996-02-29
IL91639A0 (en) 1990-04-29
DE68924818D1 (de) 1995-12-21
JPH02115767A (ja) 1990-04-27
AU4131689A (en) 1990-03-22
EP0359274A3 (en) 1990-11-28
EP0359274B1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
ATE130437T1 (de) Immuntest und reagenzien zum nachweis von durch schwangerschaft hervorgerufenem bluthochdruck und eklampsie.
ES2001811A6 (es) Un nuevo material y un nuevo dispositivo utiles en ensayos de fijacionen fase solida para determinar la presencia o la cantidad de un analito en una muestra de ensayo
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
NZ213959A (en) Immunoassay method for the determination of a particular protein analyte in a sample
AR063820A2 (es) Anticuerpo purificado y kit para detectar la prenez en un animal bovino
ATE282828T1 (de) Schnelltest zur gleichzeitigen spezifischen bestimmung von hiv-antikörpern
GR3017075T3 (en) Vaginal sample test and reagents.
ATE125572T1 (de) Immunodiagnostisches verfahren zum nachweis und zur bestimmung von euterentzündung.
ZA90136B (en) Diagnostic test using chimeric antibodies
GR3036218T3 (en) Htlv-i/htlv-ii assay and method.
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
CA2213083A1 (en) Detection of antibody production
ATE15108T1 (de) Verfahren zum nachweis von onkofoetalen antigenen, zum nachweis von krebs, zur beurteilung der krebstherapie und fuer diesen zweck geeignete diagnostische zusammenstellung.
DE3568639D1 (en) Method for the determination of a substance capable of immunological binding
GB8724549D0 (en) Immunoassay
NO903830D0 (no) Fremgangsmaate for aa bestemme antistoff og assayreagens for dette.
DE68917732T2 (de) Immuntestverfahren von chondrocalcin.
ES8608321A1 (es) Hibridomas productores de anticuerpos monoclonales especifi-cos para la inmunoglobulina e (ige)humana del mieloma ns
HUT60039A (en) Method for detecting allergy to food proteins and screening test set applicable for said method

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee